Tracking outcomes for people with high red blood cell counts
Part of Blood & lymphatic, Cancer clinical trials.
This study follows people with high red blood cell counts (erythrocytosis) who are seen at a blood specialty clinic. The goal is to track their health over time to learn more about this condition and how it affects patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have high hemoglobin levels (above 165 for men, above 160 for women).
- You must be referred to the blood clinic at London Health Sciences Centre.
- You must be able to give informed consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with certain chronic blood cancers to understand how the diseases progress and how treatments affect outcomes over time. It may help improve care for future patients.
This study looks at people who have higher-than-normal hemoglobin and platelet counts. It aims to better understand the biology behind these blood changes and how they may be related to disease.
This study tests whether lisinopril, a common blood pressure medication, can help lower red blood cell counts in people who have elevated hemoglobin levels. Researchers want to see if this drug could offer a simpler treatment option for this condition.
This study is a “registry,” meaning it collects information about adults with specific types of myeloproliferative neoplasms (MPNs). It helps researchers better understand these diseases and may improve future care.
This study looks at immune cells (monocytes) in people with certain blood cancers. Researchers want to understand how these cells behave and change over time. You can join if you are newly diagnosed and haven't started treatment yet.
This study looks at how thick your blood is (blood viscosity) if you have polycythemia, a condition where your body makes too many red blood cells. It aims to understand the relationship between blood thickness and your red blood cell levels.
Hear when a new Polycythemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.